|
|
|
Volumn 19, Issue 1, 1999, Pages 28-41
|
|
Cost-effectiveness analysis of oral ondansetron and prochlorperazine for preventing nausea and vomiting after moderately emetogenic chemotherapy.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
ONDANSETRON;
PROCHLORPERAZINE;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COMPARATIVE STUDY;
COST BENEFIT ANALYSIS;
DECISION SUPPORT SYSTEM;
DRUG COST;
ECONOMICS;
HUMAN;
NAUSEA;
ORAL DRUG ADMINISTRATION;
QUALITY ADJUSTED LIFE YEAR;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
UNITED STATES;
VOMITING;
ADMINISTRATION, ORAL;
ANTIEMETICS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
COST-BENEFIT ANALYSIS;
DECISION SUPPORT TECHNIQUES;
DRUG COSTS;
HUMANS;
NAUSEA;
ONDANSETRON;
PROCHLORPERAZINE;
QUALITY-ADJUSTED LIFE YEARS;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
UNITED STATES;
VOMITING;
|
|
EID: 0033114106
PISSN: 10805737
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
